Nanoparticles cause cancer cells to self-destruct

April 3, 2014

Using magnetically controlled nanoparticles to force tumour cells to 'self-destruct' sounds like science fiction, but could be a future part of cancer treatment, according to research from Lund University in Sweden.

"The clever thing about the technique is that we can target selected without harming surrounding tissue. There are many ways to kill cells, but this method is contained and remote-controlled", said Professor Erik Renström.

The point of the new technique is that it is much more targeted than trying to kill cancer cells with techniques such as chemotherapy. "Chemotherapy can also affect in the body, and it therefore has serious side-effects. Radiotherapy can also affect healthy tissue around the tumour.

"Our technique, on the other hand, is able to attack only the tumour cells", said Enming Zhang, one of the first authors of the study. In brief, the technique involves getting the nanoparticles into a tumour cell, where they bind to lysosomes, the units in the cell that perform 'cleaning patrols'. The lysosomes have the ability to break down foreign substances that have entered a cell. They can also break down the entire cell through a process known as 'controlled cell death', a type of destruction where damaged cells dissolve themselves.

This video is not supported by your browser at this time.

The researchers have used nanoparticles of iron oxide that have been treated with a special form of magnetism. Once the particles are inside the cancer cells, the cells are exposed to a , and the nanoparticles begin to rotate in a way that causes the lysosomes to start destroying the cells.

The research group at Lund University is not the first to try and treat cancer using supermagnetic nanoparticles. However, previous attempts have focused on using the magnetic field to create heat that kills the . The problem with this is that the heat can cause inflammation that risks harming surrounding, healthy tissue. The new method, on the other hand, in which the rotation of the can be controlled, only affects the that the nanoparticles have entered.

The new technique is primarily intended for , but according to Erik Renström and his colleague Enming Zhang there may be other areas of application. One example is autoimmune diseases such as type 1 diabetes, in which the immune system attacks the body's own insulin production.

The 'superparamagnetic nanoparticles' have attracted a lot of interest from academia and industry in recent years. They are being tested in research on new diagnostic laboratory tests, new methods of viewing phenomena in living tissue, and new drugs.

The researchers at Lund University have a patent pending for their technique with the rotating nanoparticles. However, a lot of work remains before it can be transferred from the laboratory to clinical trials on patients.

The study is a collaboration between physicists, chemists, engineers and doctors from Sweden, Germany and the USA. It has been published in the American journal ACS Nano.

Explore further: New nanoparticle delivers, tracks cancer drugs

Related Stories

New nanoparticle delivers, tracks cancer drugs

October 29, 2013

(Phys.org) —UNSW chemical engineers have synthesised a new iron oxide nanoparticle that delivers cancer drugs to cells while simultaneously monitoring the drug release in real time.

Hot nanoparticles for cancer treatments

March 24, 2014

Nanoparticles have a great deal of potential in medicine: for diagnostics, as a vehicle for active substances or a tool to kill off tumours using heat. ETH Zurich researchers have now developed particles that are relatively ...

Recommended for you

Reshaping the solar spectrum to turn light to electricity

July 28, 2015

When it comes to installing solar cells, labor cost and the cost of the land to house them constitute the bulk of the expense. The solar cells—made often of silicon or cadmium telluride—rarely cost more than 20 percent ...

Meet the high-performance single-molecule diode

July 29, 2015

A team of researchers from Berkeley Lab and Columbia University has passed a major milestone in molecular electronics with the creation of the world's highest-performance single-molecule diode. Working at Berkeley Lab's Molecular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.